{"gene":"POFUT2","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2007,"finding":"POFUT2 adds O-linked fucose to thrombospondin type 1 repeats (TSRs) of ADAMTS13, and this O-fucosylation is required for efficient secretion of ADAMTS13; siRNA knockdown of POFUT2 or expression in GDP-fucose-deficient cells reduces ADAMTS13 secretion, and mutation of individual O-fucosylation sites reduces secretion.","method":"Mass spectrometry of tryptic peptides, metabolic labeling with [3H]fucose, site-directed mutagenesis of O-fucosylation sites, siRNA knockdown of POFUT2, expression in Lec-13 (GDP-fucose-deficient) cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (MS, metabolic labeling, mutagenesis, siRNA, glycosylation-deficient cell line) in a single study","pmids":["17395589"],"is_preprint":false},{"year":2007,"finding":"POFUT2 O-fucosylates TSRs of ADAMTS-like-1/punctin-1 (at TSR2, TSR3, TSR4), and this modification is required for efficient secretion; mutation of O-fucosylation sites or expression in GDP-fucose-deficient Lec-13 cells reduces secreted punctin-1 levels.","method":"Mass spectrometry of tryptic peptides, metabolic labeling, site-directed mutagenesis, expression in Lec-13 cells with/without exogenous L-fucose","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including MS, mutagenesis, and glycosylation-deficient cell lines","pmids":["17395588"],"is_preprint":false},{"year":2006,"finding":"A novel β1,3-glucosyltransferase (B3GLCT/β3Glc-T) elongates the O-fucose added by POFUT2 on TSR domains to form a Glcβ1-3Fuc disaccharide; POFUT2 must first fucosylate the TSR before it becomes an acceptor for B3GLCT, establishing the sequential order of modification in the ER.","method":"Recombinant enzyme expression, TLC analysis of reaction products, β-glucosidase digestion, in vitro sequential enzyme assay with recombinant POFUT2 and B3GLCT on bacterially expressed TSR domain","journal":"Glycobiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of sequential enzymatic reaction with structural characterization of product","pmids":["16899492"],"is_preprint":false},{"year":2010,"finding":"Mouse POFUT2 specifically adds O-fucose to TSRs and is essential for embryonic development; Pofut2 gene-trap mutant embryos exhibit unrestricted epithelial-to-mesenchymal transition, defective mesoderm patterning, loss of epiblast pluripotency, and expanded Nodal/BMP4/Fgf8/Wnt3 signaling, consistent with POFUT2 targets being ECM components.","method":"Gene-trap mouse knockout, immunofluorescence, in situ hybridization, teratoma formation assay","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined developmental phenotype and signaling readout, replicated across two gene-trap lines","pmids":["20637190"],"is_preprint":false},{"year":2012,"finding":"Crystal structures of human POFUT2 reveal a GT-B fold variation with distinct sugar-donor (GDP-fucose) and TSR-acceptor binding sites; kinetic and mutagenesis studies show that substrate specificity is determined by recognition of the conserved 3D fold of the TSR rather than its primary sequence.","method":"X-ray crystallography of POFUT2, steady-state kinetics of wild-type and mutant POFUT2 and TSR substrates, mini-TSR substrate engineering","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and kinetic analysis in a single study","pmids":["22588082"],"is_preprint":false},{"year":2014,"finding":"POFUT2 mediates a non-canonical ER quality control mechanism: it recognizes and glycosylates folded TSRs co-translationally, stabilizing them; mass spectral analysis shows TSRs in mature secreted protein are stoichiometrically modified whereas ER-resident folding intermediates are partially modified; in vitro unfolding and refolding assays show O-fucose and O-glucose stabilize TSRs additively and POFUT2 accelerates net TSR folding.","method":"Mass spectrometry of secreted vs. ER-retained protein, in vitro unfolding assays, in vitro refolding under redox conditions with recombinant POFUT2, siRNA knockdown, secretion assays","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of folding/unfolding plus MS and cell-based secretion assays, multiple orthogonal methods","pmids":["25544610"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of C. elegans POFUT2 in complex with GDP and human TSR1 reveals an inverting mechanism for fucose transfer assisted by a catalytic base; POFUT2 embraces nearly half the TSR1 surface using a small number of direct contacts and a large network of water-mediated interactions; mutagenesis shows POFUT2 prefers threonine over serine and requires the folded TSR consensus C-X-X-S/T-C.","method":"X-ray crystallography of CePOFUT2-GDP-TSR1 fusion complex, site-directed mutagenesis, atomic-level MD simulations","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 1 — co-crystal structure of enzyme-substrate complex combined with mutagenesis and MD simulations","pmids":["26854667"],"is_preprint":false},{"year":2016,"finding":"Loss of POFUT2 in mouse embryos phenocopies loss of ADAMTS9, and CRISPR/Cas9 knockout of POFUT2 in HEK293T cells blocks secretion of ADAMTS9; conditional deletion of Pofut2 or Adamts9 in epiblast rescues gastrulation defects, indicating that defects in POFUT2 mutant embryos are primarily caused by impaired O-fucosylation and secretion of ADAMTS9 from extraembryonic tissues.","method":"Mouse knockouts (Pofut2 and Adamts9), Cre-mediated conditional deletion, CRISPR/Cas9 knockout in HEK293T cells, secretion assays, genetic epistasis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 — genetic epistasis via conditional knockout combined with biochemical secretion assay","pmids":["27297885"],"is_preprint":false},{"year":2015,"finding":"CCN1 (Cyr61) is O-fucosylated at Thr242 within its TSR1 domain by POFUT2; knockdown of POFUT2 reduces secreted and cell-surface levels of CCN1, demonstrating that O-fucosylation at this site regulates CCN1 secretion.","method":"Mass spectrometry identification of O-fucosylation site, site-directed mutagenesis (T242A), POFUT2 siRNA knockdown, secretion and cell-surface localization assays","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1-2 — MS identification of modification site, mutagenesis, and siRNA knockdown with defined secretion phenotype","pmids":["26424659"],"is_preprint":false},{"year":2017,"finding":"O-glycosylation of EGF repeats by POGLUT1 and POFUT1 (not POFUT2) cooperatively stabilizes individual EGF repeat domains through intramolecular interactions; crystal structure of an EGF repeat with O-glucose trisaccharide at 2.2 Å shows the glycan fills a surface groove with multiple protein contacts; this mechanism is analogous to POFUT2's role on TSRs.","method":"Crystal structure of glycosylated EGF repeat, in vitro EGF repeat unfolding assays, cell-surface Notch1 expression assays in HEK293T POGLUT1/POFUT1 knockout cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — relevant as comparative mechanistic context for POFUT2 ER quality control paradigm; POFUT2 itself not the primary subject of this paper","pmids":["28729422"],"is_preprint":false},{"year":2020,"finding":"ADAMTSL2 TSRs are modified with glucose-fucose disaccharide at high stoichiometry by POFUT2/B3GLCT; ADAMTSL2 secretion is lost in POFUT2−/− but not B3GLCT−/− cells; two GPHYSD1 disease mutations (S641L in TSR3, G817R in TSR6) reduce ADAMTSL2 secretion, and S641L eliminates O-fucosylation of TSR3, providing a molecular mechanism for geleophysic dysplasia.","method":"Mass spectrometry of glycan modifications, POFUT2−/− and B3GLCT−/− cell secretion assays, disease mutant analysis by MS and secretion assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — MS of modification sites combined with KO cell secretion assays and disease mutation functional analysis","pmids":["32913123"],"is_preprint":false},{"year":2022,"finding":"The Glc-Fuc disaccharide on TSR3 of thrombospondin-1 interacts with specific nearby amino acids to protect a disulfide bond; crystallographic, NMR, and MD evidence show these interactions stabilize the folded TSR; mutation of the interacting amino acids reduces the stabilizing effect of the sugars in vitro, providing a molecular mechanism for POFUT2-mediated ER quality control.","method":"X-ray crystallography, NMR spectroscopy, molecular dynamics simulations, site-directed mutagenesis, in vitro unfolding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple structural methods (crystallography, NMR, MD) combined with mutagenesis and in vitro functional assays","pmids":["35597280"],"is_preprint":false},{"year":2022,"finding":"Conditional knockout of Pofut2 in limb mesenchyme causes limb shortening and skeletal dysplasia with accumulation of fibrillin 2, decreased BMP/IHH signaling, and increased TGF-β signaling, demonstrating that O-fucosylation of TSR-containing ECM proteins by POFUT2 is required for normal ECM remodeling and signaling during bone development.","method":"Cre-mediated conditional knockout (Prrx1-Cre), immunofluorescence, signaling pathway analysis, in vitro secretion assays in POFUT2-null HEK293T cells","journal":"Matrix biology : journal of the International Society for Matrix Biology","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined skeletal phenotype and signaling readouts, supported by in vitro secretion assays","pmids":["35167946"],"is_preprint":false},{"year":2022,"finding":"POFUT2 follows a classical SN2 inverting glycosyltransferase mechanism in which water molecules facilitate release of the GDP leaving group and mediate H-transfer from the acceptor nucleophile (Thr/Ser) to the catalytic base; crystal structure of CePOFUT2 with a TSR from group 2 confirms similar recognition of TSRs from both group 1 and 2.","method":"X-ray crystallography of CePOFUT2-TSR group 2 complex, QM/MM computational analysis of reaction mechanism using human POFUT2 as model","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with QM/MM mechanistic analysis","pmids":["36260536"],"is_preprint":false},{"year":2025,"finding":"POFUT2 interacts with and fucosylates Junction Plakoglobin (JUP) in colorectal cancer cells; this fucosylation upregulates JUP protein levels and subsequently increases VEGFA expression to promote angiogenesis.","method":"Flag-immunoprecipitation with mass spectrometry, co-immunoprecipitation, western blot, angiogenesis assays with conditioned medium, immunohistochemistry","journal":"International journal of medical sciences","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP/MS identification of interaction with functional readout, but single lab, no direct in vitro fucosylation assay of JUP","pmids":["41583504"],"is_preprint":false},{"year":2026,"finding":"Estradiol upregulates POFUT2 expression in trophoblasts via the ESR2/SP1 transcription factor complex binding to the POFUT2 promoter; elevated POFUT2 promotes trophoblast syncytialization (cell fusion), and POFUT2 expression is decreased in syncytiotrophoblast of preeclampsia placentas.","method":"Chromatin immunoprecipitation (ChIP), co-immunoprecipitation of ESR2/SP1, siRNA knockdown of POFUT2, trophoblast fusion cell model, immunohistochemistry","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and co-IP establish transcriptional regulation mechanism; KD shows functional role in syncytialization","pmids":["41672297"],"is_preprint":false},{"year":2025,"finding":"NF-κB activated by IL-1β binds to the POFUT2 promoter and upregulates POFUT2 expression; elevated POFUT2 then enhances ADAMTS9 secretion (via O-fucosylation), promoting versican degradation and ECM weakening in fetal membranes.","method":"ChIP and luciferase reporter assays for NF-κB binding to POFUT2 promoter, primary human amniotic epithelial cell IL-1β treatment, murine intra-amniotic IL-1β injection model, NF-κB inhibitor rescue","journal":"Cell communication and signaling : CCS","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and luciferase assays establish transcriptional mechanism; animal model validation; pathway placement via inhibitor rescue","pmids":["40057799"],"is_preprint":false},{"year":2003,"finding":"POFUT2 constitutes a distinct protein O-fucosyltransferase family (family 2) that shares three conserved peptide motifs with POFUT1, α2-fucosyltransferases, and α6-fucosyltransferases, defining a new superfamily of fucosyltransferases with a common ancestral origin.","method":"Phylogenetic analysis, sequence motif identification, comparative genomics","journal":"Glycobiology","confidence":"Low","confidence_rationale":"Tier 4 — computational/bioinformatic analysis only","pmids":["12966037"],"is_preprint":false},{"year":2019,"finding":"B3GLCT loss differentially affects secretion of ADAMTS9 and ADAMTS20 compared to POFUT2 loss, with hydrocephalus and white spotting in B3glct mutant mice resulting from loss of ADAMTS20, eye defects from partial reduction of ADAMTS9, and cleft palate from combined loss; this demonstrates that B3GLCT-mediated glucose extension of POFUT2-added fucose is required for a subset of POFUT2 targets.","method":"Mouse B3glct knockout (two alleles), genetic epistasis, biochemical secretion assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — clean genetic models with defined developmental phenotypes and biochemical secretion assays, strong epistasis","pmids":["31600785"],"is_preprint":false}],"current_model":"POFUT2 is an ER-localized inverting glycosyltransferase (GT-B fold) that recognizes the conserved 3D structure of folded thrombospondin type 1 repeats (TSRs) — rather than their primary sequence — via a dynamic network of water-mediated interactions, and catalyzes transfer of O-fucose from GDP-fucose to serine/threonine residues within the TSR consensus C-X-X-S/T-C; this co-translational O-fucosylation stabilizes disulfide bonds and the folded TSR structure (additive with B3GLCT-mediated glucose elongation to Glcβ1-3Fuc), thereby mediating a non-canonical ER quality control mechanism that promotes efficient secretion of >40 TSR-containing proteins (including ADAMTS proteases, ADAMTSL proteins, CCN1, and ADAMTS13), and is essential for embryonic development, ECM remodeling, and tissue-specific signaling in vivo."},"narrative":{"teleology":[{"year":2003,"claim":"Establishing POFUT2 as a distinct fucosyltransferase family: phylogenetic analysis identified POFUT2 as a separate family sharing ancestral motifs with POFUT1 and other fucosyltransferases, but its enzymatic substrates and biological function were unknown.","evidence":"Phylogenetic and motif analysis across fucosyltransferase superfamily members","pmids":["12966037"],"confidence":"Low","gaps":["Computational analysis only, no experimental validation of enzymatic activity","No substrates identified","No biological phenotype assessed"]},{"year":2006,"claim":"Defining the sequential two-step glycosylation pathway: reconstitution showed POFUT2 must first add O-fucose to TSRs before B3GLCT can extend it with glucose, establishing the biosynthetic order and the Glc-β1,3-Fuc disaccharide product.","evidence":"In vitro sequential enzyme assay with recombinant POFUT2 and B3GLCT on bacterially expressed TSR, TLC and β-glucosidase characterization","pmids":["16899492"],"confidence":"High","gaps":["Biological significance of glucose extension versus fucose alone not yet tested","In vivo stoichiometry of disaccharide unknown"]},{"year":2007,"claim":"Demonstrating that POFUT2-mediated O-fucosylation is required for secretion of TSR-containing proteins: loss of POFUT2 or GDP-fucose, or mutation of O-fucosylation sites, reduced secretion of ADAMTS13 and ADAMTSL1, establishing O-fucosylation as a secretion-promoting modification.","evidence":"Mass spectrometry, metabolic labeling, site-directed mutagenesis, siRNA knockdown, and expression in GDP-fucose-deficient Lec-13 cells for both ADAMTS13 and ADAMTSL1","pmids":["17395589","17395588"],"confidence":"High","gaps":["Mechanism by which loss of fucosylation impairs secretion (folding vs. trafficking) not resolved","Number and identity of all POFUT2 substrates unknown"]},{"year":2010,"claim":"Establishing essential in vivo roles: Pofut2 knockout mouse embryos died with unrestricted EMT, defective mesoderm patterning, and expanded Nodal/BMP4 signaling, demonstrating that POFUT2-dependent O-fucosylation of ECM proteins is essential for embryonic development.","evidence":"Gene-trap mouse knockout (two alleles), immunofluorescence, in situ hybridization, teratoma assay","pmids":["20637190"],"confidence":"High","gaps":["Which specific POFUT2 substrate(s) cause the embryonic phenotype not identified","Cell-autonomous vs. non-autonomous roles not distinguished"]},{"year":2012,"claim":"Revealing POFUT2 structural architecture and substrate recognition principle: crystal structures showed a GT-B fold and demonstrated that POFUT2 recognizes the conserved 3D fold of TSRs rather than primary sequence, explaining how a single enzyme can modify diverse TSR-containing proteins.","evidence":"X-ray crystallography of human POFUT2, steady-state kinetics with wild-type and mutant enzymes, mini-TSR substrate engineering","pmids":["22588082"],"confidence":"High","gaps":["No enzyme-substrate co-crystal structure yet","Catalytic mechanism not resolved at atomic level"]},{"year":2014,"claim":"Defining a non-canonical ER quality control mechanism: O-fucosylation by POFUT2 occurs co-translationally on folded TSRs, stabilizes their disulfide bonds additively with B3GLCT-added glucose, and accelerates net TSR folding, establishing POFUT2 as an ER quality control enzyme rather than simply a secretion signal.","evidence":"Mass spectrometry of secreted vs. ER-retained protein intermediates, in vitro unfolding/refolding reconstitution with POFUT2 under redox conditions, siRNA and secretion assays","pmids":["25544610"],"confidence":"High","gaps":["Whether POFUT2 interacts with canonical ER chaperones unknown","Whether the enzyme has lectin-like folding-sensor activity beyond its catalytic role not tested"]},{"year":2016,"claim":"Resolving the enzyme-substrate complex and catalytic mechanism: co-crystal structure of CePOFUT2-GDP-TSR1 showed POFUT2 embraces nearly half the TSR surface via water-mediated interactions and uses an inverting mechanism with a catalytic base, and genetic epistasis in mice demonstrated ADAMTS9 as the critical in vivo POFUT2 substrate for gastrulation.","evidence":"X-ray crystallography of CePOFUT2-GDP-TSR1 complex, MD simulations, mutagenesis; mouse conditional KO of Pofut2 and Adamts9, CRISPR KO secretion assays","pmids":["26854667","27297885"],"confidence":"High","gaps":["Only group 1 TSR co-crystallized; group 2 TSR recognition untested structurally","Full transition-state characterization missing"]},{"year":2019,"claim":"Distinguishing the contributions of fucosylation versus glucose extension: B3glct knockout mice showed that glucose elongation of POFUT2-added fucose is differentially required for secretion of specific substrates (ADAMTS20 vs. ADAMTS9), with distinct developmental phenotypes, establishing that the disaccharide acts as a graded quality control signal.","evidence":"Mouse B3glct knockout (two alleles), genetic epistasis, secretion assays","pmids":["31600785"],"confidence":"High","gaps":["Structural basis for why some TSRs require glucose extension for secretion and others do not is unknown","Quantitative relationship between glycan stoichiometry and secretion efficiency not defined"]},{"year":2020,"claim":"Connecting POFUT2 to human disease: ADAMTSL2 secretion requires POFUT2 but not B3GLCT, and a geleophysic dysplasia mutation (S641L) in TSR3 eliminates its O-fucosylation site, providing a direct molecular mechanism linking POFUT2-dependent fucosylation to the skeletal disease geleophysic dysplasia.","evidence":"Mass spectrometry of glycan modifications, POFUT2−/− and B3GLCT−/− cell secretion assays, disease mutation analysis","pmids":["32913123"],"confidence":"High","gaps":["Whether other geleophysic dysplasia mutations act through the same O-fucosylation-dependent mechanism not tested","No patient-derived cells or rescue experiments"]},{"year":2022,"claim":"Elucidating the molecular mechanism of glycan-mediated TSR stabilization and extending POFUT2 roles to skeletal development: crystallographic/NMR evidence showed the Glc-Fuc disaccharide protects specific disulfide bonds via direct amino acid contacts, while conditional Pofut2 deletion in limb mesenchyme caused skeletal dysplasia with disrupted BMP/IHH and TGF-β signaling and aberrant ECM remodeling.","evidence":"X-ray crystallography, NMR, MD simulations, mutagenesis, in vitro unfolding assays; Prrx1-Cre conditional KO mice, signaling pathway analysis","pmids":["35597280","35167946","36260536"],"confidence":"High","gaps":["Full QM/MM transition-state for human POFUT2 not computed","Which specific TSR-containing substrates mediate the skeletal phenotype not identified","Whether POFUT2 has non-catalytic functions remains untested"]},{"year":2025,"claim":"Identifying tissue-specific transcriptional regulation and new functional contexts: NF-κB/IL-1β drives POFUT2 expression in fetal membranes to enhance ADAMTS9-mediated versican degradation, while ESR2/SP1 drives POFUT2 in trophoblasts to promote syncytialization, expanding POFUT2 roles to parturition and placentation.","evidence":"ChIP and luciferase reporter assays, primary human amniotic epithelial cells, murine intra-amniotic IL-1β injection, NF-κB inhibitor rescue; ChIP for ESR2/SP1, trophoblast fusion assays, preeclampsia tissue IHC","pmids":["40057799","41672297"],"confidence":"Medium","gaps":["Whether other POFUT2 substrates beyond ADAMTS9 contribute to fetal membrane weakening unknown","Causal role of reduced POFUT2 in preeclampsia not established beyond association","No genetic confirmation in human pregnancies"]},{"year":null,"claim":"Key unresolved questions include the full repertoire of physiologically relevant POFUT2 substrates in vivo, whether POFUT2 has non-catalytic chaperone or sensor functions, the structural basis for substrate-selective dependence on glucose extension, and whether POFUT2 dysfunction directly causes Mendelian disease in humans.","evidence":"","pmids":[],"confidence":"Low","gaps":["No complete in vivo substrate catalog","No human genetic disease directly attributed to POFUT2 mutations","Non-catalytic functions not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2,4,5,6,8,10,13]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,5]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,5,8,10]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[3,12,16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,7,12]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,1,5,8,10]}],"complexes":[],"partners":["B3GLCT","ADAMTS13","ADAMTS9","ADAMTSL1","ADAMTSL2","CCN1"],"other_free_text":[]},"mechanistic_narrative":"POFUT2 is an ER-resident inverting O-fucosyltransferase that catalyzes the transfer of fucose from GDP-fucose to serine/threonine residues within the C-X-X-S/T-C consensus of folded thrombospondin type 1 repeats (TSRs), functioning as a non-canonical ER quality control checkpoint that promotes proper folding and efficient secretion of >40 TSR-containing extracellular matrix proteins including ADAMTS proteases, ADAMTSL proteins, CCN1, and ADAMTS13 [PMID:17395589, PMID:25544610, PMID:26424659]. Crystal structures reveal a GT-B fold enzyme that recognizes the three-dimensional structure of folded TSRs rather than primary sequence, embracing nearly half the TSR surface through a dynamic network of water-mediated interactions and employing an SN2 inverting mechanism with water-assisted proton transfer [PMID:22588082, PMID:26854667, PMID:36260536]. The O-fucose modification, often elongated to a Glc-β1,3-Fuc disaccharide by B3GLCT, stabilizes TSR disulfide bonds and domain folding additively, and loss of this modification impairs secretion of client proteins leading to disrupted ECM remodeling, aberrant BMP/TGF-β/Nodal signaling, and developmental defects including embryonic lethality, skeletal dysplasia, and geleophysic dysplasia [PMID:20637190, PMID:35167946, PMID:32913123, PMID:35597280]. Pofut2-null mouse embryos phenocopy Adamts9 loss, establishing ADAMTS9 as a critical in vivo substrate, while disease mutations in ADAMTSL2 that abolish O-fucosylation sites provide a direct molecular mechanism for geleophysic dysplasia [PMID:27297885, PMID:32913123]."},"prefetch_data":{"uniprot":{"accession":"Q9Y2G5","full_name":"GDP-fucose protein O-fucosyltransferase 2","aliases":["Peptide-O-fucosyltransferase 2","O-FucT-2"],"length_aa":429,"mass_kda":50.0,"function":"GDP-fucose protein O-fucosyltransferase involved in one of the two pathways responsible for protein O-linked fucosylation, a unique post-translational modification of cysteine-knotted proteins that regulates various biological functions. This pathway targets proteins with Thrombospondin type-1 (TSP1) repeats (TSR) in the endoplasmic reticulum. Catalyzes the reaction that attaches fucose through an O-glycosidic linkage to a conserved serine or threonine residue in the consensus sequence C1-X-X-S/T-C2 of thrombospondin type I repeats (TSRs) where C1 and C2 are the first and second cysteines of the repeat, respectively (PubMed:22588082). O-fucosylates members of several protein families including the ADAMTS, the thrombospondin (TSP) and spondin families (Probable) (PubMed:17395588). Required for the proper secretion of ADAMTS family members such as ADAMTSL1 and ADAMTS13 (PubMed:17395588, PubMed:17395589). The O-fucosylation of TSRs is also required for restricting epithelial to mesenchymal transition (EMT), maintaining the correct patterning of mesoderm and localization of the definite endoderm (By similarity)","subcellular_location":"Endoplasmic reticulum; Golgi apparatus","url":"https://www.uniprot.org/uniprotkb/Q9Y2G5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POFUT2","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/POFUT2","total_profiled":1310},"omim":[{"mim_id":"610308","title":"BETA-3-GLUCOSYLTRANSFERASE; B3GLCT","url":"https://www.omim.org/entry/610308"},{"mim_id":"610249","title":"PROTEIN O-FUCOSYLTRANSFERASE 2; POFUT2","url":"https://www.omim.org/entry/610249"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POFUT2"},"hgnc":{"alias_symbol":["KIAA0958","FUT13"],"prev_symbol":["C21orf80"]},"alphafold":{"accession":"Q9Y2G5","domains":[{"cath_id":"3.40.50.11340","chopping":"42-223","consensus_level":"high","plddt":95.3619,"start":42,"end":223},{"cath_id":"3.40.50.11350","chopping":"244-407","consensus_level":"high","plddt":95.948,"start":244,"end":407}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2G5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2G5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2G5-F1-predicted_aligned_error_v6.png","plddt_mean":90.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POFUT2","jax_strain_url":"https://www.jax.org/strain/search?query=POFUT2"},"sequence":{"accession":"Q9Y2G5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y2G5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y2G5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2G5"}},"corpus_meta":[{"pmid":"10942434","id":"PMC_10942434","title":"Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome).","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10942434","citation_count":220,"is_preprint":false},{"pmid":"28729422","id":"PMC_28729422","title":"O-Glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates Notch trafficking.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28729422","citation_count":92,"is_preprint":false},{"pmid":"17395589","id":"PMC_17395589","title":"O-fucosylation is required for ADAMTS13 secretion.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17395589","citation_count":87,"is_preprint":false},{"pmid":"21966509","id":"PMC_21966509","title":"Structural insights into the mechanism of protein O-fucosylation.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21966509","citation_count":83,"is_preprint":false},{"pmid":"25544610","id":"PMC_25544610","title":"Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism.","date":"2014","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/25544610","citation_count":73,"is_preprint":false},{"pmid":"20637190","id":"PMC_20637190","title":"O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20637190","citation_count":69,"is_preprint":false},{"pmid":"17395588","id":"PMC_17395588","title":"O-fucosylation of thrombospondin type 1 repeats in ADAMTS-like-1/punctin-1 regulates secretion: implications for the ADAMTS superfamily.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17395588","citation_count":66,"is_preprint":false},{"pmid":"16899492","id":"PMC_16899492","title":"Molecular cloning and characterization of a novel human beta1,3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domain.","date":"2006","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16899492","citation_count":63,"is_preprint":false},{"pmid":"22588082","id":"PMC_22588082","title":"Structure of human POFUT2: insights into thrombospondin type 1 repeat fold and O-fucosylation.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22588082","citation_count":60,"is_preprint":false},{"pmid":"25186198","id":"PMC_25186198","title":"Novel roles for O-linked glycans in protein folding.","date":"2014","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/25186198","citation_count":59,"is_preprint":false},{"pmid":"26854667","id":"PMC_26854667","title":"A proactive role of water molecules in acceptor recognition by protein O-fucosyltransferase 2.","date":"2016","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/26854667","citation_count":55,"is_preprint":false},{"pmid":"12966037","id":"PMC_12966037","title":"A new superfamily of protein-O-fucosyltransferases, alpha2-fucosyltransferases, and alpha6-fucosyltransferases: phylogeny and identification of conserved peptide motifs.","date":"2003","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/12966037","citation_count":55,"is_preprint":false},{"pmid":"28916755","id":"PMC_28916755","title":"Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28916755","citation_count":51,"is_preprint":false},{"pmid":"27297885","id":"PMC_27297885","title":"Genetic and biochemical evidence that gastrulation defects in Pofut2 mutants result from defects in ADAMTS9 secretion.","date":"2016","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27297885","citation_count":39,"is_preprint":false},{"pmid":"30101373","id":"PMC_30101373","title":"Fucosylation genes as circulating biomarkers for lung cancer.","date":"2018","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30101373","citation_count":32,"is_preprint":false},{"pmid":"30545422","id":"PMC_30545422","title":"Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals.","date":"2018","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/30545422","citation_count":28,"is_preprint":false},{"pmid":"25165882","id":"PMC_25165882","title":"LIF upregulates poFUT1 expression and promotes trophoblast cell migration and invasion at the fetal-maternal interface.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25165882","citation_count":27,"is_preprint":false},{"pmid":"26424659","id":"PMC_26424659","title":"O-Fucosylation of CCN1 is required for its secretion.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/26424659","citation_count":26,"is_preprint":false},{"pmid":"31600785","id":"PMC_31600785","title":"ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.","date":"2019","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31600785","citation_count":25,"is_preprint":false},{"pmid":"23045360","id":"PMC_23045360","title":"6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin type-1 repeats by protein O-fucosyltransferases 1 and 2.","date":"2012","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23045360","citation_count":24,"is_preprint":false},{"pmid":"27773385","id":"PMC_27773385","title":"Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.","date":"2016","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/27773385","citation_count":23,"is_preprint":false},{"pmid":"30538131","id":"PMC_30538131","title":"O-Fucosylation of thrombospondin-like repeats is required for processing of microneme protein 2 and for efficient host cell invasion by Toxoplasma gondii tachyzoites.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30538131","citation_count":23,"is_preprint":false},{"pmid":"16679357","id":"PMC_16679357","title":"Molecular evolution of protein O-fucosyltransferase genes and splice variants.","date":"2006","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16679357","citation_count":22,"is_preprint":false},{"pmid":"32913123","id":"PMC_32913123","title":"O-Fucosylation of ADAMTSL2 is required for secretion and is impacted by geleophysic dysplasia-causing mutations.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32913123","citation_count":22,"is_preprint":false},{"pmid":"30084393","id":"PMC_30084393","title":"A perspective on structural and mechanistic aspects of protein O-fucosylation.","date":"2018","source":"Acta crystallographica. Section F, Structural biology communications","url":"https://pubmed.ncbi.nlm.nih.gov/30084393","citation_count":16,"is_preprint":false},{"pmid":"30514763","id":"PMC_30514763","title":"Protein O-fucosyltransferase 2-mediated O-glycosylation of the adhesin MIC2 is dispensable for Toxoplasma gondii tachyzoite infection.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30514763","citation_count":16,"is_preprint":false},{"pmid":"39775168","id":"PMC_39775168","title":"FUT10 and FUT11 are protein O-fucosyltransferases that modify protein EMI domains.","date":"2025","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/39775168","citation_count":15,"is_preprint":false},{"pmid":"15233996","id":"PMC_15233996","title":"The Caenorhabditis elegans ortholog of C21orf80, a potential new protein O-fucosyltransferase, is required for normal development.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15233996","citation_count":14,"is_preprint":false},{"pmid":"35167946","id":"PMC_35167946","title":"O-fucosylation of thrombospondin type 1 repeats is essential for ECM remodeling and signaling during bone development.","date":"2022","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35167946","citation_count":14,"is_preprint":false},{"pmid":"29367452","id":"PMC_29367452","title":"Systematic Functional Characterization of Human 21st Chromosome Orthologs in Caenorhabditis elegans.","date":"2018","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/29367452","citation_count":14,"is_preprint":false},{"pmid":"36852302","id":"PMC_36852302","title":"Fucosyltransferases Regulated by Fusobacterium Nucleatum and Act as Novel Biomarkers in Colon Adenocarcinoma.","date":"2023","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/36852302","citation_count":12,"is_preprint":false},{"pmid":"31334132","id":"PMC_31334132","title":"Protein O-Fucosyltransferase 2 Is Not Essential for Plasmodium berghei Development.","date":"2019","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31334132","citation_count":12,"is_preprint":false},{"pmid":"35597280","id":"PMC_35597280","title":"O-fucosylation stabilizes the TSR3 motif in thrombospondin-1 by interacting with nearby amino acids and protecting a disulfide bond.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35597280","citation_count":9,"is_preprint":false},{"pmid":"40286076","id":"PMC_40286076","title":"Protein O-Fucosyltransferases: Biological Functions and Molecular Mechanisms in Mammals.","date":"2025","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/40286076","citation_count":8,"is_preprint":false},{"pmid":"36260536","id":"PMC_36260536","title":"The Essential Role of Water Molecules in the Reaction Mechanism of Protein O-Fucosyltransferase 2.","date":"2022","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/36260536","citation_count":7,"is_preprint":false},{"pmid":"36757621","id":"PMC_36757621","title":"Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer.","date":"2023","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36757621","citation_count":7,"is_preprint":false},{"pmid":"38421807","id":"PMC_38421807","title":"Protein O-Fucosyltransferase Is Required for the Efficient Invasion of Hepatocytes by Plasmodium berghei Sporozoites.","date":"2024","source":"ACS infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38421807","citation_count":5,"is_preprint":false},{"pmid":"40049660","id":"PMC_40049660","title":"Knockout of the fcsk gene in zebrafish causes neurodevelopmental defects.","date":"2025","source":"Zoological research","url":"https://pubmed.ncbi.nlm.nih.gov/40049660","citation_count":3,"is_preprint":false},{"pmid":"28910607","id":"PMC_28910607","title":"Molecular cloning and functional expression of Lewis type α1,3/α1,4-fucosyltransferase cDNAs from Mangifera indica L.","date":"2017","source":"Phytochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28910607","citation_count":3,"is_preprint":false},{"pmid":"31463900","id":"PMC_31463900","title":"Analyzing the Effects of O-Fucosylation on Secretion of ADAMTS Proteins Using Cell-Based Assays.","date":"2020","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/31463900","citation_count":3,"is_preprint":false},{"pmid":"36721988","id":"PMC_36721988","title":"O-fucosylation of thrombospondin type I repeats is dispensable for trafficking thrombospondin 1 to platelet secretory granules.","date":"2023","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/36721988","citation_count":2,"is_preprint":false},{"pmid":"40057799","id":"PMC_40057799","title":"IL-1β stimulates ADAMTS9 expression and contributes to preterm prelabor rupture of membranes.","date":"2025","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/40057799","citation_count":1,"is_preprint":false},{"pmid":"38095646","id":"PMC_38095646","title":"Transcriptome research of human amniocytes identifies hub genes associated with developmental dysplasia in down syndrome.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/38095646","citation_count":1,"is_preprint":false},{"pmid":"41672297","id":"PMC_41672297","title":"Estradiol promotes trophoblasts syncytization by upregulating ESR2/SP1 transcription factor-mediated poFUT2 expression.","date":"2026","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/41672297","citation_count":0,"is_preprint":false},{"pmid":"41583504","id":"PMC_41583504","title":"POFUT2 Mediated Fucosylation of JUP Enhances VEGFA Expression to Promote Angiogenesis in Colorectal Cancer.","date":"2026","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41583504","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25328,"output_tokens":5027,"usd":0.075694},"stage2":{"model":"claude-opus-4-6","input_tokens":8586,"output_tokens":3434,"usd":0.19317},"total_usd":0.268864,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"POFUT2 adds O-linked fucose to thrombospondin type 1 repeats (TSRs) of ADAMTS13, and this O-fucosylation is required for efficient secretion of ADAMTS13; siRNA knockdown of POFUT2 or expression in GDP-fucose-deficient cells reduces ADAMTS13 secretion, and mutation of individual O-fucosylation sites reduces secretion.\",\n      \"method\": \"Mass spectrometry of tryptic peptides, metabolic labeling with [3H]fucose, site-directed mutagenesis of O-fucosylation sites, siRNA knockdown of POFUT2, expression in Lec-13 (GDP-fucose-deficient) cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (MS, metabolic labeling, mutagenesis, siRNA, glycosylation-deficient cell line) in a single study\",\n      \"pmids\": [\"17395589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"POFUT2 O-fucosylates TSRs of ADAMTS-like-1/punctin-1 (at TSR2, TSR3, TSR4), and this modification is required for efficient secretion; mutation of O-fucosylation sites or expression in GDP-fucose-deficient Lec-13 cells reduces secreted punctin-1 levels.\",\n      \"method\": \"Mass spectrometry of tryptic peptides, metabolic labeling, site-directed mutagenesis, expression in Lec-13 cells with/without exogenous L-fucose\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including MS, mutagenesis, and glycosylation-deficient cell lines\",\n      \"pmids\": [\"17395588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A novel β1,3-glucosyltransferase (B3GLCT/β3Glc-T) elongates the O-fucose added by POFUT2 on TSR domains to form a Glcβ1-3Fuc disaccharide; POFUT2 must first fucosylate the TSR before it becomes an acceptor for B3GLCT, establishing the sequential order of modification in the ER.\",\n      \"method\": \"Recombinant enzyme expression, TLC analysis of reaction products, β-glucosidase digestion, in vitro sequential enzyme assay with recombinant POFUT2 and B3GLCT on bacterially expressed TSR domain\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of sequential enzymatic reaction with structural characterization of product\",\n      \"pmids\": [\"16899492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mouse POFUT2 specifically adds O-fucose to TSRs and is essential for embryonic development; Pofut2 gene-trap mutant embryos exhibit unrestricted epithelial-to-mesenchymal transition, defective mesoderm patterning, loss of epiblast pluripotency, and expanded Nodal/BMP4/Fgf8/Wnt3 signaling, consistent with POFUT2 targets being ECM components.\",\n      \"method\": \"Gene-trap mouse knockout, immunofluorescence, in situ hybridization, teratoma formation assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined developmental phenotype and signaling readout, replicated across two gene-trap lines\",\n      \"pmids\": [\"20637190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structures of human POFUT2 reveal a GT-B fold variation with distinct sugar-donor (GDP-fucose) and TSR-acceptor binding sites; kinetic and mutagenesis studies show that substrate specificity is determined by recognition of the conserved 3D fold of the TSR rather than its primary sequence.\",\n      \"method\": \"X-ray crystallography of POFUT2, steady-state kinetics of wild-type and mutant POFUT2 and TSR substrates, mini-TSR substrate engineering\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and kinetic analysis in a single study\",\n      \"pmids\": [\"22588082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"POFUT2 mediates a non-canonical ER quality control mechanism: it recognizes and glycosylates folded TSRs co-translationally, stabilizing them; mass spectral analysis shows TSRs in mature secreted protein are stoichiometrically modified whereas ER-resident folding intermediates are partially modified; in vitro unfolding and refolding assays show O-fucose and O-glucose stabilize TSRs additively and POFUT2 accelerates net TSR folding.\",\n      \"method\": \"Mass spectrometry of secreted vs. ER-retained protein, in vitro unfolding assays, in vitro refolding under redox conditions with recombinant POFUT2, siRNA knockdown, secretion assays\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of folding/unfolding plus MS and cell-based secretion assays, multiple orthogonal methods\",\n      \"pmids\": [\"25544610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of C. elegans POFUT2 in complex with GDP and human TSR1 reveals an inverting mechanism for fucose transfer assisted by a catalytic base; POFUT2 embraces nearly half the TSR1 surface using a small number of direct contacts and a large network of water-mediated interactions; mutagenesis shows POFUT2 prefers threonine over serine and requires the folded TSR consensus C-X-X-S/T-C.\",\n      \"method\": \"X-ray crystallography of CePOFUT2-GDP-TSR1 fusion complex, site-directed mutagenesis, atomic-level MD simulations\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — co-crystal structure of enzyme-substrate complex combined with mutagenesis and MD simulations\",\n      \"pmids\": [\"26854667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Loss of POFUT2 in mouse embryos phenocopies loss of ADAMTS9, and CRISPR/Cas9 knockout of POFUT2 in HEK293T cells blocks secretion of ADAMTS9; conditional deletion of Pofut2 or Adamts9 in epiblast rescues gastrulation defects, indicating that defects in POFUT2 mutant embryos are primarily caused by impaired O-fucosylation and secretion of ADAMTS9 from extraembryonic tissues.\",\n      \"method\": \"Mouse knockouts (Pofut2 and Adamts9), Cre-mediated conditional deletion, CRISPR/Cas9 knockout in HEK293T cells, secretion assays, genetic epistasis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis via conditional knockout combined with biochemical secretion assay\",\n      \"pmids\": [\"27297885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCN1 (Cyr61) is O-fucosylated at Thr242 within its TSR1 domain by POFUT2; knockdown of POFUT2 reduces secreted and cell-surface levels of CCN1, demonstrating that O-fucosylation at this site regulates CCN1 secretion.\",\n      \"method\": \"Mass spectrometry identification of O-fucosylation site, site-directed mutagenesis (T242A), POFUT2 siRNA knockdown, secretion and cell-surface localization assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — MS identification of modification site, mutagenesis, and siRNA knockdown with defined secretion phenotype\",\n      \"pmids\": [\"26424659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"O-glycosylation of EGF repeats by POGLUT1 and POFUT1 (not POFUT2) cooperatively stabilizes individual EGF repeat domains through intramolecular interactions; crystal structure of an EGF repeat with O-glucose trisaccharide at 2.2 Å shows the glycan fills a surface groove with multiple protein contacts; this mechanism is analogous to POFUT2's role on TSRs.\",\n      \"method\": \"Crystal structure of glycosylated EGF repeat, in vitro EGF repeat unfolding assays, cell-surface Notch1 expression assays in HEK293T POGLUT1/POFUT1 knockout cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — relevant as comparative mechanistic context for POFUT2 ER quality control paradigm; POFUT2 itself not the primary subject of this paper\",\n      \"pmids\": [\"28729422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ADAMTSL2 TSRs are modified with glucose-fucose disaccharide at high stoichiometry by POFUT2/B3GLCT; ADAMTSL2 secretion is lost in POFUT2−/− but not B3GLCT−/− cells; two GPHYSD1 disease mutations (S641L in TSR3, G817R in TSR6) reduce ADAMTSL2 secretion, and S641L eliminates O-fucosylation of TSR3, providing a molecular mechanism for geleophysic dysplasia.\",\n      \"method\": \"Mass spectrometry of glycan modifications, POFUT2−/− and B3GLCT−/− cell secretion assays, disease mutant analysis by MS and secretion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — MS of modification sites combined with KO cell secretion assays and disease mutation functional analysis\",\n      \"pmids\": [\"32913123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The Glc-Fuc disaccharide on TSR3 of thrombospondin-1 interacts with specific nearby amino acids to protect a disulfide bond; crystallographic, NMR, and MD evidence show these interactions stabilize the folded TSR; mutation of the interacting amino acids reduces the stabilizing effect of the sugars in vitro, providing a molecular mechanism for POFUT2-mediated ER quality control.\",\n      \"method\": \"X-ray crystallography, NMR spectroscopy, molecular dynamics simulations, site-directed mutagenesis, in vitro unfolding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple structural methods (crystallography, NMR, MD) combined with mutagenesis and in vitro functional assays\",\n      \"pmids\": [\"35597280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Conditional knockout of Pofut2 in limb mesenchyme causes limb shortening and skeletal dysplasia with accumulation of fibrillin 2, decreased BMP/IHH signaling, and increased TGF-β signaling, demonstrating that O-fucosylation of TSR-containing ECM proteins by POFUT2 is required for normal ECM remodeling and signaling during bone development.\",\n      \"method\": \"Cre-mediated conditional knockout (Prrx1-Cre), immunofluorescence, signaling pathway analysis, in vitro secretion assays in POFUT2-null HEK293T cells\",\n      \"journal\": \"Matrix biology : journal of the International Society for Matrix Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined skeletal phenotype and signaling readouts, supported by in vitro secretion assays\",\n      \"pmids\": [\"35167946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"POFUT2 follows a classical SN2 inverting glycosyltransferase mechanism in which water molecules facilitate release of the GDP leaving group and mediate H-transfer from the acceptor nucleophile (Thr/Ser) to the catalytic base; crystal structure of CePOFUT2 with a TSR from group 2 confirms similar recognition of TSRs from both group 1 and 2.\",\n      \"method\": \"X-ray crystallography of CePOFUT2-TSR group 2 complex, QM/MM computational analysis of reaction mechanism using human POFUT2 as model\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with QM/MM mechanistic analysis\",\n      \"pmids\": [\"36260536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"POFUT2 interacts with and fucosylates Junction Plakoglobin (JUP) in colorectal cancer cells; this fucosylation upregulates JUP protein levels and subsequently increases VEGFA expression to promote angiogenesis.\",\n      \"method\": \"Flag-immunoprecipitation with mass spectrometry, co-immunoprecipitation, western blot, angiogenesis assays with conditioned medium, immunohistochemistry\",\n      \"journal\": \"International journal of medical sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP/MS identification of interaction with functional readout, but single lab, no direct in vitro fucosylation assay of JUP\",\n      \"pmids\": [\"41583504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Estradiol upregulates POFUT2 expression in trophoblasts via the ESR2/SP1 transcription factor complex binding to the POFUT2 promoter; elevated POFUT2 promotes trophoblast syncytialization (cell fusion), and POFUT2 expression is decreased in syncytiotrophoblast of preeclampsia placentas.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), co-immunoprecipitation of ESR2/SP1, siRNA knockdown of POFUT2, trophoblast fusion cell model, immunohistochemistry\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and co-IP establish transcriptional regulation mechanism; KD shows functional role in syncytialization\",\n      \"pmids\": [\"41672297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NF-κB activated by IL-1β binds to the POFUT2 promoter and upregulates POFUT2 expression; elevated POFUT2 then enhances ADAMTS9 secretion (via O-fucosylation), promoting versican degradation and ECM weakening in fetal membranes.\",\n      \"method\": \"ChIP and luciferase reporter assays for NF-κB binding to POFUT2 promoter, primary human amniotic epithelial cell IL-1β treatment, murine intra-amniotic IL-1β injection model, NF-κB inhibitor rescue\",\n      \"journal\": \"Cell communication and signaling : CCS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and luciferase assays establish transcriptional mechanism; animal model validation; pathway placement via inhibitor rescue\",\n      \"pmids\": [\"40057799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"POFUT2 constitutes a distinct protein O-fucosyltransferase family (family 2) that shares three conserved peptide motifs with POFUT1, α2-fucosyltransferases, and α6-fucosyltransferases, defining a new superfamily of fucosyltransferases with a common ancestral origin.\",\n      \"method\": \"Phylogenetic analysis, sequence motif identification, comparative genomics\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/bioinformatic analysis only\",\n      \"pmids\": [\"12966037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"B3GLCT loss differentially affects secretion of ADAMTS9 and ADAMTS20 compared to POFUT2 loss, with hydrocephalus and white spotting in B3glct mutant mice resulting from loss of ADAMTS20, eye defects from partial reduction of ADAMTS9, and cleft palate from combined loss; this demonstrates that B3GLCT-mediated glucose extension of POFUT2-added fucose is required for a subset of POFUT2 targets.\",\n      \"method\": \"Mouse B3glct knockout (two alleles), genetic epistasis, biochemical secretion assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic models with defined developmental phenotypes and biochemical secretion assays, strong epistasis\",\n      \"pmids\": [\"31600785\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POFUT2 is an ER-localized inverting glycosyltransferase (GT-B fold) that recognizes the conserved 3D structure of folded thrombospondin type 1 repeats (TSRs) — rather than their primary sequence — via a dynamic network of water-mediated interactions, and catalyzes transfer of O-fucose from GDP-fucose to serine/threonine residues within the TSR consensus C-X-X-S/T-C; this co-translational O-fucosylation stabilizes disulfide bonds and the folded TSR structure (additive with B3GLCT-mediated glucose elongation to Glcβ1-3Fuc), thereby mediating a non-canonical ER quality control mechanism that promotes efficient secretion of >40 TSR-containing proteins (including ADAMTS proteases, ADAMTSL proteins, CCN1, and ADAMTS13), and is essential for embryonic development, ECM remodeling, and tissue-specific signaling in vivo.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POFUT2 is an ER-resident inverting O-fucosyltransferase that catalyzes the transfer of fucose from GDP-fucose to serine/threonine residues within the C-X-X-S/T-C consensus of folded thrombospondin type 1 repeats (TSRs), functioning as a non-canonical ER quality control checkpoint that promotes proper folding and efficient secretion of >40 TSR-containing extracellular matrix proteins including ADAMTS proteases, ADAMTSL proteins, CCN1, and ADAMTS13 [PMID:17395589, PMID:25544610, PMID:26424659]. Crystal structures reveal a GT-B fold enzyme that recognizes the three-dimensional structure of folded TSRs rather than primary sequence, embracing nearly half the TSR surface through a dynamic network of water-mediated interactions and employing an SN2 inverting mechanism with water-assisted proton transfer [PMID:22588082, PMID:26854667, PMID:36260536]. The O-fucose modification, often elongated to a Glc-β1,3-Fuc disaccharide by B3GLCT, stabilizes TSR disulfide bonds and domain folding additively, and loss of this modification impairs secretion of client proteins leading to disrupted ECM remodeling, aberrant BMP/TGF-β/Nodal signaling, and developmental defects including embryonic lethality, skeletal dysplasia, and geleophysic dysplasia [PMID:20637190, PMID:35167946, PMID:32913123, PMID:35597280]. Pofut2-null mouse embryos phenocopy Adamts9 loss, establishing ADAMTS9 as a critical in vivo substrate, while disease mutations in ADAMTSL2 that abolish O-fucosylation sites provide a direct molecular mechanism for geleophysic dysplasia [PMID:27297885, PMID:32913123].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing POFUT2 as a distinct fucosyltransferase family: phylogenetic analysis identified POFUT2 as a separate family sharing ancestral motifs with POFUT1 and other fucosyltransferases, but its enzymatic substrates and biological function were unknown.\",\n      \"evidence\": \"Phylogenetic and motif analysis across fucosyltransferase superfamily members\",\n      \"pmids\": [\"12966037\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational analysis only, no experimental validation of enzymatic activity\", \"No substrates identified\", \"No biological phenotype assessed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defining the sequential two-step glycosylation pathway: reconstitution showed POFUT2 must first add O-fucose to TSRs before B3GLCT can extend it with glucose, establishing the biosynthetic order and the Glc-β1,3-Fuc disaccharide product.\",\n      \"evidence\": \"In vitro sequential enzyme assay with recombinant POFUT2 and B3GLCT on bacterially expressed TSR, TLC and β-glucosidase characterization\",\n      \"pmids\": [\"16899492\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biological significance of glucose extension versus fucose alone not yet tested\", \"In vivo stoichiometry of disaccharide unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that POFUT2-mediated O-fucosylation is required for secretion of TSR-containing proteins: loss of POFUT2 or GDP-fucose, or mutation of O-fucosylation sites, reduced secretion of ADAMTS13 and ADAMTSL1, establishing O-fucosylation as a secretion-promoting modification.\",\n      \"evidence\": \"Mass spectrometry, metabolic labeling, site-directed mutagenesis, siRNA knockdown, and expression in GDP-fucose-deficient Lec-13 cells for both ADAMTS13 and ADAMTSL1\",\n      \"pmids\": [\"17395589\", \"17395588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which loss of fucosylation impairs secretion (folding vs. trafficking) not resolved\", \"Number and identity of all POFUT2 substrates unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing essential in vivo roles: Pofut2 knockout mouse embryos died with unrestricted EMT, defective mesoderm patterning, and expanded Nodal/BMP4 signaling, demonstrating that POFUT2-dependent O-fucosylation of ECM proteins is essential for embryonic development.\",\n      \"evidence\": \"Gene-trap mouse knockout (two alleles), immunofluorescence, in situ hybridization, teratoma assay\",\n      \"pmids\": [\"20637190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific POFUT2 substrate(s) cause the embryonic phenotype not identified\", \"Cell-autonomous vs. non-autonomous roles not distinguished\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealing POFUT2 structural architecture and substrate recognition principle: crystal structures showed a GT-B fold and demonstrated that POFUT2 recognizes the conserved 3D fold of TSRs rather than primary sequence, explaining how a single enzyme can modify diverse TSR-containing proteins.\",\n      \"evidence\": \"X-ray crystallography of human POFUT2, steady-state kinetics with wild-type and mutant enzymes, mini-TSR substrate engineering\",\n      \"pmids\": [\"22588082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No enzyme-substrate co-crystal structure yet\", \"Catalytic mechanism not resolved at atomic level\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defining a non-canonical ER quality control mechanism: O-fucosylation by POFUT2 occurs co-translationally on folded TSRs, stabilizes their disulfide bonds additively with B3GLCT-added glucose, and accelerates net TSR folding, establishing POFUT2 as an ER quality control enzyme rather than simply a secretion signal.\",\n      \"evidence\": \"Mass spectrometry of secreted vs. ER-retained protein intermediates, in vitro unfolding/refolding reconstitution with POFUT2 under redox conditions, siRNA and secretion assays\",\n      \"pmids\": [\"25544610\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether POFUT2 interacts with canonical ER chaperones unknown\", \"Whether the enzyme has lectin-like folding-sensor activity beyond its catalytic role not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolving the enzyme-substrate complex and catalytic mechanism: co-crystal structure of CePOFUT2-GDP-TSR1 showed POFUT2 embraces nearly half the TSR surface via water-mediated interactions and uses an inverting mechanism with a catalytic base, and genetic epistasis in mice demonstrated ADAMTS9 as the critical in vivo POFUT2 substrate for gastrulation.\",\n      \"evidence\": \"X-ray crystallography of CePOFUT2-GDP-TSR1 complex, MD simulations, mutagenesis; mouse conditional KO of Pofut2 and Adamts9, CRISPR KO secretion assays\",\n      \"pmids\": [\"26854667\", \"27297885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Only group 1 TSR co-crystallized; group 2 TSR recognition untested structurally\", \"Full transition-state characterization missing\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Distinguishing the contributions of fucosylation versus glucose extension: B3glct knockout mice showed that glucose elongation of POFUT2-added fucose is differentially required for secretion of specific substrates (ADAMTS20 vs. ADAMTS9), with distinct developmental phenotypes, establishing that the disaccharide acts as a graded quality control signal.\",\n      \"evidence\": \"Mouse B3glct knockout (two alleles), genetic epistasis, secretion assays\",\n      \"pmids\": [\"31600785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for why some TSRs require glucose extension for secretion and others do not is unknown\", \"Quantitative relationship between glycan stoichiometry and secretion efficiency not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connecting POFUT2 to human disease: ADAMTSL2 secretion requires POFUT2 but not B3GLCT, and a geleophysic dysplasia mutation (S641L) in TSR3 eliminates its O-fucosylation site, providing a direct molecular mechanism linking POFUT2-dependent fucosylation to the skeletal disease geleophysic dysplasia.\",\n      \"evidence\": \"Mass spectrometry of glycan modifications, POFUT2−/− and B3GLCT−/− cell secretion assays, disease mutation analysis\",\n      \"pmids\": [\"32913123\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other geleophysic dysplasia mutations act through the same O-fucosylation-dependent mechanism not tested\", \"No patient-derived cells or rescue experiments\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Elucidating the molecular mechanism of glycan-mediated TSR stabilization and extending POFUT2 roles to skeletal development: crystallographic/NMR evidence showed the Glc-Fuc disaccharide protects specific disulfide bonds via direct amino acid contacts, while conditional Pofut2 deletion in limb mesenchyme caused skeletal dysplasia with disrupted BMP/IHH and TGF-β signaling and aberrant ECM remodeling.\",\n      \"evidence\": \"X-ray crystallography, NMR, MD simulations, mutagenesis, in vitro unfolding assays; Prrx1-Cre conditional KO mice, signaling pathway analysis\",\n      \"pmids\": [\"35597280\", \"35167946\", \"36260536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full QM/MM transition-state for human POFUT2 not computed\", \"Which specific TSR-containing substrates mediate the skeletal phenotype not identified\", \"Whether POFUT2 has non-catalytic functions remains untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying tissue-specific transcriptional regulation and new functional contexts: NF-κB/IL-1β drives POFUT2 expression in fetal membranes to enhance ADAMTS9-mediated versican degradation, while ESR2/SP1 drives POFUT2 in trophoblasts to promote syncytialization, expanding POFUT2 roles to parturition and placentation.\",\n      \"evidence\": \"ChIP and luciferase reporter assays, primary human amniotic epithelial cells, murine intra-amniotic IL-1β injection, NF-κB inhibitor rescue; ChIP for ESR2/SP1, trophoblast fusion assays, preeclampsia tissue IHC\",\n      \"pmids\": [\"40057799\", \"41672297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether other POFUT2 substrates beyond ADAMTS9 contribute to fetal membrane weakening unknown\", \"Causal role of reduced POFUT2 in preeclampsia not established beyond association\", \"No genetic confirmation in human pregnancies\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full repertoire of physiologically relevant POFUT2 substrates in vivo, whether POFUT2 has non-catalytic chaperone or sensor functions, the structural basis for substrate-selective dependence on glucose extension, and whether POFUT2 dysfunction directly causes Mendelian disease in humans.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No complete in vivo substrate catalog\", \"No human genetic disease directly attributed to POFUT2 mutations\", \"Non-catalytic functions not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2, 4, 5, 6, 8, 10, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 5, 8, 10]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [3, 12, 16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 7, 12]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 1, 5, 8, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"B3GLCT\",\n      \"ADAMTS13\",\n      \"ADAMTS9\",\n      \"ADAMTSL1\",\n      \"ADAMTSL2\",\n      \"CCN1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}